Quest Diagnostics Incorporated (DGX) 當前追蹤本益比 (P/E) 為 22.1, 前瞻本益比為 18.3. 追蹤盈利收益率為 4.52%, 前瞻盈利收益率 5.48%. PEG 1.60. 葛拉漢數為 $114.89.
本頁證實的標準:
SharesGrow 綜合評分： 55/100 其中 1/7 項標準通過。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | 19.9 | -2.89 | 2.78 | 1.71 | 1.73% |
| 2017 | 17.5 | 0.76 | 2.74 | 1.75 | 1.83% |
| 2018 | 15.4 | -3.94 | 2.17 | 1.50 | 2.35% |
| 2019 | 16.7 | 0.93 | 2.54 | 1.85 | 2.00% |
| 2020 | 11.2 | 0.17 | 2.36 | 1.69 | 1.86% |
| 2021 | 10.8 | 0.22 | 3.36 | 2.00 | 1.43% |
| 2022 | 19.2 | -0.39 | 3.08 | 1.84 | 1.68% |
| 2023 | 18.1 | -2.77 | 2.45 | 1.67 | 2.03% |
| 2024 | 19.2 | 6.95 | 2.47 | 1.70 | 1.98% |
| 2025 | 19.4 | 1.42 | 2.69 | 1.75 | 1.83% |
| Year | EPS（稀釋） | 營收 | 淨利潤 | 淨利潤率 |
|---|---|---|---|---|
| 2016 | $4.51 | $7.52B | $645M | 8.6% |
| 2017 | $5.50 | $7.71B | $772M | 10% |
| 2018 | $5.29 | $7.53B | $736M | 9.8% |
| 2019 | $6.29 | $7.73B | $858M | 11.1% |
| 2020 | $10.52 | $9.44B | $1.43B | 15.2% |
| 2021 | $15.53 | $10.79B | $2B | 18.5% |
| 2022 | $7.98 | $9.88B | $946M | 9.6% |
| 2023 | $7.52 | $9.25B | $854M | 9.2% |
| 2024 | $7.69 | $9.87B | $871M | 8.8% |
| 2025 | $8.75 | $11.04B | $992M | 9% |
| Year | EPS（平均） | EPS 範圍 | 營收（平均） | 營收範圍 | 分析師人數 |
|---|---|---|---|---|---|
| 2026 | $10.64 | $10.54 – $10.75 | $11.76B | $11.71B – $11.9B | 12 |
| 2027 | $11.47 | $11.22 – $11.85 | $12.2B | $11.87B – $12.56B | 12 |
| 2028 | $12.49 | $11.82 – $13.50 | $12.76B | $12.75B – $12.76B | 7 |
| 2029 | $13.89 | $13.50 – $14.19 | $13.42B | $13.13B – $13.65B | 2 |
